Liver Metastasis Does Not Impact Efficacy of ICIs in Gastroesophageal Cancer, Data Suggest
More research is needed to refine treatment strategies and identify predictive biomarkers for patient selection, according to researchers.
More research is needed to refine treatment strategies and identify predictive biomarkers for patient selection, according to researchers.
Screening for donor-derived clonal hematopoiesis may have prognostic value for outcomes following auto-HSCT in patients with hematologic malignancies.
Retreatment with venetoclax plus rituximab generated responses in patients with CLL who had responded to and progressed after initial venetoclax treatment.
In the first part of this roundtable series moderated by Tanya Dorff, MD, the panelists discuss the use of PSMA PET scans and androgen deprivation…
The Frontiers in Cancer Science 2024 conference in Singapore includes a thematic focus on immuno-oncology, genomics, metabolism, and AI.
An abstract is unavailable.
Saeed Sadeghi, MD, discusses the impact of health care resource utilization on treatment decisions and quality of life for patients with myelodysplastic syndromes (MDS), highlighting…
Adding savolitinib to osimertinib produced clinically meaningful responses in EGFR-mutant, MET-overexpressed NSCLC following progression on osimertinib.
Welcome! You are invited to join a meeting: The Legacy of Giovana Thomas: Equitable Care and Outcomes in Otolaryngology. After registering, you will receive a…
In Ukraine, a country of around 44 million people, over 1.3 million individuals currently live with cancer. To access this subscriber-only content please log in…
NCI has launched a second-generation precision medicine clinical trial called Myeloid Malignancies Molecular Analysis for Therapy Choice, or myeloMATCH, a trial focused on acute myeloid…